Not Tagged
Not Tagged
[]
tnfi &amp; disease activity-guided dose optimization in ra prog of ada or eta daily dose (100%66%50%0%) 10yrs followup in 170pts 74% tapered until full discontinuation median time to restart 8 mo 21% never restarted! what's lacking? % of recovery op0131 #eular23 
MD, PhD @UofGlasgow UK. Chair of EULAR live course subcommittee. Past Co-chair @EULAR Synovitis Study Group. CrossFit athlete and Mountains lover. Views my own.